Journal of Vascular & Interventional Radiology Cites Improved Recovery and Quality-of-Life with VNUS Technology SAN JOSE, Calif., June 10 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies...
Over Half a Million Varicose Vein Patients Treated with VNUS Closure Procedure Worldwide SAN JOSE, Calif., June 8 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (NASDAQ:VNUS), a...
(Updates with VNUS first-quarter earnings details) DOW JONES NEWSWIRES Covidien Ltd. (COV) will acquire medical-device maker VNUS Medical Technologies Inc. (VNUS) for $440 million as it looks to...
Covidien Ltd. (COV) will acquire medical-device maker VNUS Medical Technologies Inc. (VNUS) for $440 million as it looks to expand its presence in the vascular market. Unlike many of its rivals...
VNUS? Medical Technologies, Inc. (Nasdaq:VNUS), a leading provider of medical devices for the minimally invasive treatment of venous disease, today announced its financial...
Covidien (NYSE: COV) and VNUS Medical Technologies, Inc. (NASDAQ: VNUS) today announced that Covidien has reached a definitive agreement to acquire VNUS, a developer of medical...
VNUS? Medical Technologies, Inc. (Nasdaq:VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today that it...
Minimally Invasive Treatment for Varicose Veins to be showcased at National Health Service EXPO SAN JOSE, Calif., April 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc...
SAN JOSE, Calif., March 19 /PRNewswire-FirstCall/ -- VNUS Medical Technologies, Inc. (NASDAQ:VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux...
$27.2 Million Net Revenues, $0.21 Net Income Per Share SAN JOSE, Calif., Feb. 10 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (NASDAQ:VNUS), a leading provider of medical devices...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.